Dow Up 2.00% Nasdaq Up 1.66%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
0.79 Up 0.03(3.67%) Feb 12, 4:00PM EST
Prev Close:0.76
Open:0.80
Bid:0.77 x 500
Ask:0.78 x 600
1y Target Est:2.30
Beta:0.117001
Next Earnings Date:N/A
Day's Range:0.75 - 0.82
52wk Range:0.74 - 2.35
Volume:62,622
Avg Vol (3m):382,169
Market Cap:78.33M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PLXUp 3.67%78.33M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.50
Quarterly EPS Est (Dec-15) :0.68
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):0.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback